Cerebras is not worth owning because its proprietary stack faces limited broad adoption. The attached analysis says NVIDIA-aligned cloud operators are unlikely to deploy Cerebras hardware, while Groq LPUs fit NVIDIA's software ecosystem more easily. It also flags Cerebras' scaling and deployment friction, despite solid product-market fit with marquee customers. x.com 

Cerebras is difficult for retail investors to understand, and management has not done a great job explaining its business since going public. It deserves more attention as the most direct AI IPO of 2026, but going long Cerebras is hard to justify when Nvidia can be owned instead. x.com 

Cerebras looks attractive because the short report's two-year wafer-life thesis rests on unvalidated reliability assumptions, not representative failure data. Energy per useful token, lower warranty utilization and ordinary repair accounting also undercut its financial conclusions. OpenAI has integrated Cerebras into production; AMD and AWS have announced integrations, while Oracle plans 2027 availability for ultra-fast inference, adding commercial validation despite the report. x.com  x.com 

Cerebras is a stock to avoid in a cash-out environment where companies, executives, employees and early investors are selling to buyers. Per a WSJ report cited by @wallstengine, Nvidia's AI chip business is over 400x larger than Cerebras and growing nearly as fast, yet Cerebras trades around 134x trailing revenue, more than 5x Nvidia's multiple. x.com 

Cerebras is not worth owning at about $90 billion in value on roughly $500 million of revenue. A post the author replies to adds that it has only two customers and argues investment banks are using retail investors for exit liquidity. x.com 

Cerebras is a speculative, high-risk, high-reward bet on faster inference that could make its $44B market cap a multi-bagger if it works. Putting the whole processor and memory on one wafer wins on speed, not cheaper memory, since on-chip SRAM costs more per bit than HBM; Nvidia is answering via Groq. G42 and MBZUAI were 86% of 2025 revenue, but the ramp ahead is tied to OpenAI. The $160s level has held as support four times since the IPO. Size it to one's capital-preservation goals. x.com 

Nvidia's valuation gives too little credit to its expected long-term earnings growth. Its forward P/E-to-growth ratio is 0.28, the lowest since late 2023; the bullish read depends on those growth expectations proving accurate. x.com  x.com 

Cerebras's share price already assumes years of flawless execution, so investors can be right about the company long term and still lose money. Two customers make up 86% of revenue, it posted a $146 million operating loss in 2025, its GAAP profit came from accounting gains, and it trades at 111x revenue. The wafer-scale technology, 15x faster AI inference and $20B+ OpenAI compute deal make the bull case real, but the price leaves no margin for early-stage setbacks. x.com 

Cerebras Systems offers the fastest AI inference chip available, a single wafer-sized processor with the model's memory on the chip, running inference several times faster than GPU systems. It has a $25.4B backlog, about 30x this year's revenue, partnerships with OpenAI, AMD and AWS, and no exposure to rising HBM prices. Concerns: a 14.2% GAAP gross margin, about $600M of free cash flow burned in the first half, roughly 80% of backlog tied to OpenAI, and about 171M shares unlocking in November. … Show more

Cerebras is unattractive to buy at a valuation above $60 billion while its product remains unproven at scale. x.com